INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 192 filers reported holding INSMED INC in Q3 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $980,862 | +21.3% | 38,846 | +1.4% | 0.01% | +14.3% |
| Q2 2023 | $808,552 | +20.8% | 38,320 | -2.4% | 0.01% | +16.7% |
| Q1 2023 | $669,298 | -11.2% | 39,255 | +4.0% | 0.01% | -14.3% |
| Q4 2022 | $753,925 | +7.7% | 37,734 | +16.2% | 0.01% | 0.0% |
| Q3 2022 | $700,000 | +10.2% | 32,479 | +0.8% | 0.01% | +16.7% |
| Q2 2022 | $635,000 | -15.6% | 32,223 | +0.7% | 0.01% | 0.0% |
| Q1 2022 | $752,000 | -10.6% | 31,998 | +3.6% | 0.01% | 0.0% |
| Q4 2021 | $841,000 | -1.2% | 30,892 | -0.1% | 0.01% | -14.3% |
| Q3 2021 | $851,000 | +6.8% | 30,914 | +10.4% | 0.01% | +16.7% |
| Q2 2021 | $797,000 | -21.1% | 28,010 | -5.5% | 0.01% | -33.3% |
| Q1 2021 | $1,010,000 | +3.1% | 29,654 | +0.8% | 0.01% | 0.0% |
| Q4 2020 | $980,000 | 0.0% | 29,430 | -3.5% | 0.01% | -10.0% |
| Q3 2020 | $980,000 | +58.6% | 30,485 | +35.8% | 0.01% | +11.1% |
| Q2 2020 | $618,000 | +93.7% | 22,452 | +12.7% | 0.01% | +80.0% |
| Q1 2020 | $319,000 | – | 19,926 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 1,056,797 | $33,965,000 | 14.39% |
| Palo Alto Investors LP | 6,032,956 | $193,899,000 | 10.64% |
| Sycale Advisors (NY) LLC | 360,829 | $11,597,000 | 9.99% |
| Burrage Capital Management LLC | 165,400 | $5,316,000 | 4.20% |
| First Light Asset Management, LLC | 1,025,341 | $32,954,000 | 3.38% |
| Rubric Capital Management LP | 1,100,000 | $35,354,000 | 3.30% |
| Sofinnova Investments, Inc. | 615,143 | $19,771,000 | 1.47% |
| Endurant Capital Management LP | 144,313 | $4,638,000 | 1.37% |
| Parkwood LLC | 70,235 | $5,514,000 | 0.85% |
| Novo Holdings A/S | 430,107 | $13,824,000 | 0.69% |